Finance

Lists
MDNAF:OTCMKTS
Medicenna Therapeutics Corp
0,30 $
-1,28%
(-0,0039) 1D
14 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDNAF...
Open
0,28 $
High
0,32 $
Low
0,28 $
Mkt. cap
40,15 млн
Avg. vol.
46,82 мың
Volume
29,72 мың
52-wk high
1,43 $
52-wk low
0,23 $
Beta
1,97
Shares outstanding
92,30 млн
No. of employees
15
Open
0,28 $
High
0,32 $
Low
0,28 $
Mkt. cap
40,15 млн
Avg. vol.
46,82 мың
Volume
29,72 мың
52-wk high
1,43 $
52-wk low
0,23 $
Beta
1,97
Shares outstanding
92,30 млн
No. of employees
15
News stories
From web sources and news partners
About Medicenna Therapeutics Corp
CEO-
Employees15
Founded2015
HeadquartersТоронто, Онтарио, Канада
Sector-
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,11 млн
4,07 млн
4,50 млн
4,24 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,36 млн
1,54 млн
1,32 млн
1,21 млн
Operating expense
5,47 млн
5,62 млн
5,82 млн
5,45 млн
Total operating expenses
5,47 млн
5,62 млн
5,82 млн
5,45 млн
Operating income
-5,47 млн
-5,62 млн
-5,82 млн
-5,45 млн
Other non operating income
200,00 м.
1,29 млн
1,51 млн
400,00 м.
EBT including unusual items
-4,88 млн
-4,36 млн
-4,23 млн
-5,08 млн
EBT excluding unusual items
-4,88 млн
-4,36 млн
-4,23 млн
-5,08 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,88 млн
-4,36 млн
-4,23 млн
-5,08 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
158,00 м.
114,00 м.
53,00 мың
25,00 мың
Interest expense
-
-
-
-
Net interest expenses
158,00 м.
114,00 м.
53,00 мың
25,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,46 млн
-5,61 млн
-5,82 млн
-5,45 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары